Precision BioSciences/$DTIL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Precision BioSciences
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Ticker
$DTIL
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
108
ISIN
US74019P2074
Website
DTIL Metrics
BasicAdvanced
$49M
-
-$2.79
-
-
Price and volume
Market cap
$49M
52-week high
$13.44
52-week low
$3.61
Average daily volume
162K
Financial strength
Total debt to equity
53.278
Interest coverage (TTM)
-28.22%
Management effectiveness
Valuation
Price to revenue (TTM)
0.717
Price to book
0.68
Price to tangible book (TTM)
0.68
Growth
Revenue change (TTM)
-11.11%
Earnings per share change (TTM)
-57.92%
3-year revenue growth (CAGR)
-20.69%
3-year earnings per share growth (CAGR)
-48.26%
What the Analysts think about DTIL
Analyst ratings (Buy, Hold, Sell) for Precision BioSciences stock.
DTIL Financial Performance
Revenues and expenses
DTIL Earnings Performance
Company profitability
DTIL News
AllArticlesVideos
Precision BioSciences Accelerates Development of PBGENE-DMD Within its Wholly Owned Organic Pipeline and Highlights Pre-clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Business Wire·1 week ago
Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025
Business Wire·2 weeks ago
Precision BioSciences Announces Presentation of Initial Safety Data from the Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV at the 2025 European Association for the Study of the Liver Congress (EASL)
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Precision BioSciences stock?
Precision BioSciences (DTIL) has a market cap of $49M as of May 23, 2025.
What is the P/E ratio for Precision BioSciences stock?
The price to earnings (P/E) ratio for Precision BioSciences (DTIL) stock is 0 as of May 23, 2025.
Does Precision BioSciences stock pay dividends?
No, Precision BioSciences (DTIL) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Precision BioSciences dividend payment date?
Precision BioSciences (DTIL) stock does not pay dividends to its shareholders.
What is the beta indicator for Precision BioSciences?
Precision BioSciences (DTIL) does not currently have a Beta indicator.